Insider Ledger
CNSP insider buying and SEC filings, explained
CNS Pharmaceuticals, Inc. · CIK 1729427
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- NV
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$44K
Insiders who bought
2
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| May 18, 2026 | Purchase (code P) | Michal Fisher (Director) bought 2,000 shares at $5.00 ($10K), reported as a purchase (code P). New position of 2,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 18, 2026 |
| May 18, 2026 | Purchase (code P) | Faith L. Charles (Director) bought 7,100 shares at $4.79 ($34K), reported as a purchase (code P). New position of 7,100 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 20, 2026 |
11 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
2 insiders bought in 30 days
$44K in purchases since May 18, 2026 · Purchases traded May 18, 2026 to May 18, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Faith L. Charles (Director) | $34K | May 18, 2026 | SEC filing |
| Michal Fisher (Director) | $10K | May 18, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow CNSP in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.